Jacobs Levy Equity Management Inc. Cuts Holdings in Semler Scientific, Inc. (NASDAQ:SMLR)

Jacobs Levy Equity Management Inc. decreased its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 57.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 41,945 shares of the company’s stock after selling 55,792 shares during the quarter. Jacobs Levy Equity Management Inc. owned approximately 0.45% of Semler Scientific worth $2,265,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of SMLR. BNP Paribas Financial Markets purchased a new stake in Semler Scientific during the 4th quarter worth about $30,000. Jones Financial Companies Lllp purchased a new stake in Semler Scientific during the 4th quarter worth about $34,000. Larson Financial Group LLC purchased a new stake in Semler Scientific during the 4th quarter worth about $38,000. NewEdge Advisors LLC increased its holdings in Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company’s stock worth $40,000 after purchasing an additional 557 shares during the period. Finally, IFP Advisors Inc purchased a new stake in Semler Scientific during the 4th quarter worth about $54,000. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital upped their price target on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.

Semler Scientific Stock Performance

Shares of NASDAQ SMLR opened at $31.79 on Friday. Semler Scientific, Inc. has a fifty-two week low of $21.77 and a fifty-two week high of $81.56. The firm has a market capitalization of $305.09 million, a PE ratio of 6.47 and a beta of 1.33. The stock’s 50-day simple moving average is $34.88 and its 200-day simple moving average is $46.63.

Semler Scientific (NASDAQ:SMLR) last issued its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The business had revenue of $8.84 million for the quarter.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.